StockData
Ocugen, Inc. logo

Ocugen, Inc. (OCGN) stock

OCGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 4, 2026Score 1/30
$0.74−0.02 (-2.31%)

Close on Nov 18, 2026Market cap $250.67MP/E –Yield –

Ocugen shares outstanding

Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.

Ocugen's shares outstanding was 339M at Jun 30, 2026. For fiscal 2023 it was 244M, up 13.9% from the year before. The highest annual figure on record is 244M in fiscal 2023.

Annual shares outstanding

PeriodPeriod endValueChange
FY2023Dec 31, 2023244M+13.9%
FY2022Dec 31, 2022215M+10.0%
FY2021Dec 31, 2021195M+73.8%
FY2020Dec 31, 2020112M+707.8%
FY2019Dec 31, 201914M+180.1%
FY2018Dec 31, 20185M+31.3%
FY2017Dec 31, 20174M+57.5%
FY2016Dec 31, 20162M+8.8%
FY2015Dec 31, 20152M+762.5%
FY2014Dec 31, 20140M–

Quarterly shares outstanding

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026339M+31.6%
Q1 FY2026Mar 31, 2026328M+27.3%
Q2 FY2025Jun 30, 2025292M+13.8%
Q1 FY2025Mar 31, 2025292M+13.8%
Q2 FY2024Jun 30, 2024257M+8.0%
Q1 FY2024Mar 31, 2024257M+14.1%
Q4 FY2023Dec 31, 2023257M+16.6%
Q3 FY2023Sep 30, 2023256M+18.4%
Q2 FY2023Jun 30, 2023238M+10.4%
Q1 FY2023Mar 31, 2023226M+9.6%
Q4 FY2022Dec 31, 2022220M+10.5%
Q3 FY2022Sep 30, 2022217M+9.0%
Q2 FY2022Jun 30, 2022216M+10.4%
Q1 FY2022Mar 31, 2022206M+10.4%
Q4 FY2021Dec 31, 2021199M+16.8%
Q3 FY2021Sep 30, 2021199M+40.4%
Q2 FY2021Jun 30, 2021196M+134.1%
Q1 FY2021Mar 31, 2021186M+254.0%
Q4 FY2020Dec 31, 2020171M+2561.7%
Q3 FY2020Sep 30, 2020142M+2233.6%
Q2 FY2020Jun 30, 202084M+1584.0%
Q1 FY2020Mar 31, 202053M+960.9%
Q3 FY2019Sep 30, 20196M+29.2%
Q2 FY2019Jun 30, 20196M-99.9%
Q1 FY2019Mar 31, 20195M-99.9%
Q4 FY2018Dec 31, 20185M+23.9%
Q3 FY2018Sep 30, 20185M+32.0%
Q2 FY2018Jun 30, 20184.79B+129454.1%
Q1 FY2018Mar 31, 20184.61B+126166.8%
Q4 FY2017Dec 31, 20174M+35.6%
Q3 FY2017Sep 30, 20174M+69.6%
Q2 FY2017Jun 30, 20174M–
Q1 FY2017Mar 31, 20174M–
Q4 FY2016Dec 31, 20163M–
Q3 FY2016Sep 30, 20162M–

More Ocugen figures

See a number that looks wrong?